1. Home
  2. NMIH vs HTFL Comparison

NMIH vs HTFL Comparison

Compare NMIH & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NMI Holdings Inc.

NMIH

NMI Holdings Inc.

HOLD

Current Price

$37.51

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

HTFL

Heartflow Inc. Common Stock

N/A

Current Price

$27.38

Market Cap

2.3B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NMIH
HTFL
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
NMIH
HTFL
Price
$37.51
$27.38
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$41.20
$39.50
AVG Volume (30 Days)
408.3K
666.3K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
9.56
N/A
EPS
4.79
N/A
Revenue
$692,208,000.00
$161,881,000.00
Revenue This Year
N/A
$40.42
Revenue Next Year
$4.79
$22.27
P/E Ratio
$7.85
N/A
Revenue Growth
8.86
85.70
52 Week Low
$31.90
$25.75
52 Week High
$43.20
$41.22

Technical Indicators

Market Signals
Indicator
NMIH
HTFL
Relative Strength Index (RSI) 49.45 N/A
Support Level $37.91 N/A
Resistance Level $38.90 N/A
Average True Range (ATR) 0.70 0.00
MACD -0.00 0.00
Stochastic Oscillator 41.45 0.00

Price Performance

Historical Comparison
NMIH
HTFL

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

About HTFL Heartflow Inc. Common Stock

HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.

Share on Social Networks: